Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > JAK1


Brief Information

Name:Tyrosine-protein kinase JAK1
Target Synonym:JAK1B,Tyrosine-protein kinase JAK1,JAK1,Janus Kinase 1,JAK1A,EC,JAK-1,JTK3,EC:,EC 2.7.10
Number of Launched Drugs:7
Number of Drugs in Clinical Trials:31
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
JA1-H5547 Human Human JAK1 Protein, His Tag
ACRO Quality

Synonym Name



JAK1 is a human tyrosine kinase protein essential for signaling for certain type I and type II cytokines. It interacts with the common gamma chain (?c) of type I cytokine receptors, to elicit signals from the IL-2 receptor family (e.g. IL-2R, IL-7R, IL-9R and IL-15R), the IL-4 receptor family (e.g. IL-4R and IL-13R), the gp130 receptor family (e.g. IL-6R, IL-11R, LIF-R, OSM-R, cardiotrophin-1 receptor (CT-1R), ciliary neurotrophic factor receptor (CNTF-R), neurotrophin-1 receptor (NNT-1R) and Leptin-R). Jak1 plays a critical role in initiating responses to multiple major cytokine receptor families. Expression of JAK1 in cancer cells enables individual cells to contract, potentially allowing them to escape their tumor and metastasize to other parts of the body

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Peficitinib ASP-015K; JNJ-54781532 Approved Astellas Pharma Inc Smyraf Japan Arthritis, Rheumatoid Astellas Pharma Inc 2019-03-29 Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative Details
Filgotinib Maleate G-146034-101; GS-6034; G-146034; GLPG-0634 Approved Galapagos Nv Jyseleca EU Colitis, Ulcerative Gilead Sciences Kk 2020-09-24 Non-radiographic axial spondyloarthritis; Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Lupus Erythematosus, Cutaneous; Spondylitis, Ankylosing; Sjogren's Syndrome; Kidney Diseases; Lupus Nephritis; Glomerulonephritis, Membranous; Colitis, Ulcerative; Arthritis, Psoriatic; Uveitis; Crohn Disease Details
Abrocitinib PF-4965842; PF-04965842 Approved Pfizer Inc 希必可, Cibinqo United Kingdom Dermatitis, Atopic Pfizer Inc 2021-09-09 Psoriasis; Dermatitis, Atopic; Eczema; Skin Diseases, Genetic; Hypersensitivity; Hypersensitivity, Immediate; Prurigo; Hepatic Insufficiency; Food Hypersensitivity; Pruritus; Granuloma Annulare; Genetic Diseases, Inborn; Skin Diseases, Eczematous; Immune System Diseases; Skin Diseases; Dermatitis; Kidney Diseases; Sarcoidosis Details
Upadacitinib ABT-494 Approved Abbvie Inc Rinvoq United States Arthritis, Rheumatoid Abbvie Inc 2019-08-16 Non-radiographic axial spondyloarthritis; Giant Cell Arteritis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Spondylarthritis; Arthritis, Juvenile; Lupus Erythematosus, Systemic; Takayasu Arteritis; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Dermatitis, Atopic; Crohn Disease; Vitiligo Details
Ruxolitinib Phosphate INCB-018424; INC-424; INCB-424; INCB-18424 Approved Incyte Corp Jakafi, Jakavi, OPZELURA United States Primary Myelofibrosis Incyte Corp 2011-11-16 Coronavirus Infections; Carcinoma, Squamous Cell; Lymphoma; Lichen Planus; Hyperplasia; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Hepatomegaly; Leukemia, Myeloid, Chronic-Phase; Primary Myelofibrosis; Lymphohistiocytosis, Hemophagocytic; Carcinoma, Intraductal, Noninfiltrating; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ectodermal Dysplasia; Breast Neoplasms; Leukemia, Neutrophilic, Chronic; Psoriasis; Prostatic Neoplasms; Thrombocytosis; Hidradenitis Suppurativa; Cachexia; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lichen Sclerosus et Atrophicus; Splenomegaly; Thrombocythemia, Essential; Vitiligo; Dermatitis, Atopic; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Eczema; Leukemia, Large Granular Lymphocytic; Leukemia, T-Cell; Myelodysplastic-Myeloproliferative Diseases; Cytokine Release Syndrome; Arthritis, Rheumatoid; Leukemia, Myelomonocytic, Chronic; Graft vs Host Disease; Myeloproliferative Disorders; Alopecia Areata; Lupus Erythematosus, Discoid; Squamou Details
Baricitinib LY-3009104; INCB-028050 Approved Incyte Corp 艾乐明, Olumiant EU Arthritis, Rheumatoid Eli Lilly Nederland BV 2017-02-13 Liver Diseases; Dermatitis, Atopic; Renal Insufficiency, Chronic; Wounds and Injuries; Skin Diseases, Papulosquamous; Skin Ulcer; Hepatic Insufficiency; Diabetic Nephropathies; Severe Acute Respiratory Syndrome; Pyoderma; Coronavirus Infections; Psoriasis; Lupus Erythematosus, Systemic; Lupus Nephritis; Polymyalgia Rheumatica; Conjunctivitis; Infections; Skin Diseases; Arthritis, Juvenile; Pemphigoid, Benign Mucous Membrane; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid; Nephritis; Dermatomyositis; Pyoderma Gangrenosum; Myositis; Alopecia Areata; HIV Infections; Liver Cirrhosis, Biliary; Diabetes Mellitus, Type 1 Details
Tofacitinib Citrate Tasocitinib; BI-764524; CP-690550; AC-1101; IMG 003; CP-690550-10; CKD-374; SSS-32 Approved Pfizer Inc Jakvinus, Xeljanz, 尚杰 United States Arthritis, Rheumatoid Pf Prism Cv 2012-11-06 Uveitis; Arthritis, Juvenile; Lung Diseases, Interstitial; Lung Diseases; Psoriasis; Lupus Erythematosus, Systemic; Granuloma Annulare; Arthritis, Psoriatic; Colitis, Ulcerative; Hepatic Insufficiency; Sarcoidosis, Pulmonary; Dry Eye Syndromes; Inflammation; Granulomatous Disease, Chronic; Hidradenitis Suppurativa; Crohn Disease; Diabetic Retinopathy; Vitiligo; Dermatitis, Atopic; Plaque psoriasis; Eczema; Arthritis, Rheumatoid; Rejection of renal transplantation; Keratoconjunctivitis Sicca; Alopecia Areata; Scleritis; Lupus Erythematosus, Discoid; Gastrointestinal Diseases; Down Syndrome; Sacroiliitis; Depression; Dermatomyositis; Alopecia; Spondylitis, Ankylosing; Scleroderma, Systemic; Coronavirus Disease 2019 (COVID-19); Lupus Erythematosus, Cutaneous; Sjogren's Syndrome; Sarcoidosis; Kidney Diseases; Spondylitis; Glioblastoma Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Fingolimod/Tofacitinib FMX-114 Phase 2 Clinical Vyne Therapeutics Inc Dermatitis, Atopic Details
TT-00420/Atezolizumab Phase 1 Clinical TransThera Sciences (Nanjing) Inc Gastrointestinal Neoplasms Details
MAX-40070 MAX-40070 Phase 1 Clinical Maxinovel Pty Ltd Alopecia Areata Details
FZJ-003 FZJ-003 Phase 1 Clinical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Arthritis, Rheumatoid; Dermatitis, Atopic Details
Elsubrutinib/Upadacitinib ABBV-599 Phase 1 Clinical Abbvie Inc Arthritis, Rheumatoid; Lupus Erythematosus, Systemic Details
LW-402 LW-402 Phase 2 Clinical Shanghai Longwood Biopharmaceuticals Co Ltd Arthritis, Rheumatoid; Dermatitis, Atopic Details
GLPG-3121 GLPG-3121 Phase 1 Clinical Galapagos Nv Details
LBG-1600M Phase 1 Clinical Suzhou Longbotai Pharmaceutical Co Ltd Dermatitis, Atopic Details
H-018 H018; H-018 Phase 1 Clinical Jiangsu Carephar Pharmaceutical Co Ltd, Nanjing Shenzhou Jiamei Pharmaceutical Co Ltd Arthritis, Rheumatoid Details
TLL-018 TLL-018 Phase 2 Clinical Tll Pharmaceutical Llc Chronic Urticaria; Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative; Urticaria Details
NIP-046 NIP-046 Phase 1 Clinical National Institutes Of Pharmaceutical Research And Development Co Ltd Arthritis, Rheumatoid Details
LNK-01002 LNK01002 Phase 1 Clinical Lynk Pharmaceutical (Hangzhou) Co Ltd Hematologic Neoplasms; Myeloproliferative Disorders; Primary Myelofibrosis; Leukemia, Myeloid, Acute Details
PG-011 PG-011 Phase 2 Clinical Prime Gene Therapeutics Co Ltd Epidermolysis Bullosa; Rhinitis, Allergic; Prurigo; Eye Diseases; Dermatitis, Atopic Details
QY201 QY-201; QY201 Phase 2 Clinical E-nitiate Biopharmaceuticals (Hangzhou) Co Ltd Alopecia Areata; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Dermatitis, Atopic Details
GDC-0214 RG-6151; GDC-0214 Phase 1 Clinical Genentech Inc Asthma Details
WXFL-10203614 WXFL-10203614 Phase 2 Clinical Wuxi Fuxin Pharmaceutical Research And Development Co Ltd, Wuxi Apptec Co Ltd Arthritis, Rheumatoid Details
AQ-280 AQ-280 Phase 1 Clinical Aqilion AB Eosinophilic Esophagitis Details
Tinengotinib TT-00420 Phase 2 Clinical TransThera Sciences (Nanjing) Inc Solid tumours; Biliary Tract Neoplasms; Stomach Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms; Sarcoma; Thyroid Neoplasms; Gallbladder Neoplasms Details
VC-005 VC-005 Phase 1 Clinical Jiangsu Vcare Pharmatech Co Ltd Inflammatory Bowel Diseases; Joint Diseases; Colitis, Ulcerative; Crohn Disease; Vitiligo; Dermatitis, Atopic Details
Golidocitinib NC-0322; AZD-4205; DZD-4205 Phase 2 Clinical Astrazeneca Plc, Dizal (Jiangsu) Pharmaceutical Co Ltd Lymphoma, T-Cell, Peripheral; Lymphoma, T-Cell, Cutaneous; Carcinoma, Non-Small-Cell Lung Details
WXSH-0150 WXSH-0150; TUL-01101 Phase 1 Clinical Zhuhai United Laboratories Co Ltd Arthritis, Rheumatoid; Dermatitis, Atopic Details
Povorcitinib INCB-54707; INCB54707; INCB054707; INCB-054707 Phase 3 Clinical Incyte Corp Renal Insufficiency; Kidney Diseases; Prurigo; Hidradenitis Suppurativa; Vitiligo Details
Brepocitinib PF-06700841-15; PF-6700841; PF-841; PF-06700841 Phase 3 Clinical Pfizer Inc Alopecia; Dermatomyositis; Alopecia Areata; Kidney Diseases; Lupus Erythematosus, Systemic; Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Hidradenitis Suppurativa; Vitiligo; Dermatitis, Atopic; Crohn Disease Details
LNK-01001 LNK01001; LNK-01001 Phase 2 Clinical Lynk Pharmaceutical (Hangzhou) Co Ltd Spondylitis, Ankylosing; Arthritis, Rheumatoid; Dermatitis, Atopic Details
ATI-1777 Phase 2 Clinical Aclaris Therapeutics Inc Dermatitis, Atopic Details
Ivarmacitinib sulfate SHR-0302; ARQ-252 Phase 3 Clinical Jiangsu Hengrui Medicine Co Ltd Non-radiographic axial spondyloarthritis; Alopecia Areata; Arthritis, Rheumatoid; Spondylarthritis; Spondylitis, Ankylosing; Colitis, Ulcerative; Arthritis, Psoriatic; Hepatic Insufficiency; Dermatitis, Atopic; Vitiligo; Crohn Disease; Eczema Details
Itacitinib INCB-039110-adipate; INCB-39110; INCB-039110; IBI-377 Phase 3 Clinical Incyte Corp Lymphoma; Psoriasis; Hemic and Lymphatic Diseases; Thrombocytosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Sarcoma; Colitis, Ulcerative; Primary Myelofibrosis; Asthma; Colorectal Neoplasms; Lymphohistiocytosis, Hemophagocytic; Sarcoma, Synovial; Lung Neoplasms; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Endometrial Neoplasms; Myelodysplastic-Myeloproliferative Diseases; Neoplasm Metastasis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Liposarcoma, Myxoid; Melanoma; Carcinoma, Renal Cell; Cytokine Release Syndrome; Leukemia; Lymphoma, B-Cell; Bronchiolitis Obliterans; Solid tumours; Head and Neck Neoplasms; Chondrosarcoma; Leiomyosarcoma; Polycythemia Vera; Pruritus; Hematologic Neoplasms; Arthritis, Rheumatoid; Graft vs Host Disease; Hodgkin Disease; Neoplasms; Myelodysplastic Syndromes; Myeloproliferative Disorders; Leukemia, Myelomonocytic, Chronic; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Liposarcoma Details
Deuterated Ruxolitinib CTP-543 Phase 3 Clinical Concert Alopecia Areata; Kidney Diseases; Hepatic Insufficiency Details
VVN-461 VVN461e; VVN-461 Phase 1 Clinical VivaVision Biotech Inc Uveitis, Anterior; Uveitis Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message